Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Income Statement [Abstract]
Sale of product	$ 6,552,149	$ 7,062,196
Cost of product	3,707,558	4,359,234
Gross profit	2,844,591	2,702,962
Operating costs and expenses:
Salaries and contract labor	1,782,774	1,675,020
General, administrative and consulting	2,053,518	1,648,147
Research and development	511,283	821,453
Total operating expenses	4,347,575	4,144,620
Operating loss	(1,502,984)	(1,441,658)
Other income (expense):
Other income	6,605	23,955
Equity in net income of affiliate	73,957	89,279
Interest income	938	438
Interest expense	(474,059)	(497,994)
Total other (expense)	(392,559)	(384,322)
Net loss	(1,895,543)	(1,825,980)
Loss attributable to noncontrolling interest	(16,431)	(7,755)
Net loss attributable to International Isotopes Inc.	$ (1,879,112)	$ (1,818,225)
Net loss per common share - basic and diluted	$ 0.00	$ 0.00
Weighted average common shares outstanding - basic and diluted	403,302,425	398,055,278